Rare HBV Genotypes and Clinically Relevant Mutations of HBV and HCV During the COVID-19 Pandemic in a National Reference Outpatient Clinic in Rio de Janeiro, Brazil.

doi:10.3390/v18080872

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Rare HBV Genotypes and Clinically Relevant Mutations of HBV and HCV During the COVID-19 Pandemic in a National Reference Outpatient Clinic in Rio de Janeiro, Brazil.

Viruses - 10 Aug 2026

da Silva Lucas Lima, do Lago Bárbara Vieira, da Costa Vanessa Duarte, de Sousa Viviane Brandão Gomes, Lewis-Ximenez Lia Laura, de Paula Vanessa Salete, Villar Livia Melo

Abstract excerpt

Chronic hepatitis B and C are major causes of cirrhosis, hepatocellular carcinoma, and liver-related mortality worldwide. The genetic diversity of hepatitis B virus (HBV) and hepatitis C virus (HCV) influences disease progression, diagnosis, vaccine response, and antiviral treatment. Periods of healthcare disruption, such as the COVID-19 pandemic, reinforce the importance of molecular surveillance to monitor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Ambulatory Care Facilities
Share to Brazil

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Cross-Sectional Studies

Share to Hepacivirus

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Source

Open in PubMed Open full text

Identifiers

PMID: 42655690
DOI: 10.3390/v18080872
PMCID: PMC13517627

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.